These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 15716328)

  • 1. Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease.
    Ninichuk V; Gross O; Reichel C; Khandoga A; Pawar RD; Ciubar R; Segerer S; Belemezova E; Radomska E; Luckow B; Perez de Lema G; Murphy PM; Gao JL; Henger A; Kretzler M; Horuk R; Weber M; Krombach F; Schlöndorff D; Anders HJ
    J Am Soc Nephrol; 2005 Apr; 16(4):977-85. PubMed ID: 15716328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome.
    Vielhauer V; Berning E; Eis V; Kretzler M; Segerer S; Strutz F; Horuk R; Gröne HJ; Schlöndorff D; Anders HJ
    Kidney Int; 2004 Dec; 66(6):2264-78. PubMed ID: 15569315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ccl2/Mcp-1 blockade reduces glomerular and interstitial macrophages but does not ameliorate renal pathology in collagen4A3-deficient mice with autosomal recessive Alport nephropathy.
    Clauss S; Gross O; Kulkarni O; Avila-Ferrufino A; Radomska E; Segerer S; Eulberg D; Klussmann S; Anders HJ
    J Pathol; 2009 May; 218(1):40-7. PubMed ID: 19156777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with BX471, a nonpeptide CCR1 antagonist, protects mice against acute pancreatitis-associated lung injury by modulating neutrophil recruitment.
    He M; Horuk R; Bhatia M
    Pancreas; 2007 Mar; 34(2):233-41. PubMed ID: 17312463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice.
    Anders HJ; Belemezova E; Eis V; Segerer S; Vielhauer V; Perez de Lema G; Kretzler M; Cohen CD; Frink M; Horuk R; Hudkins KL; Alpers CE; Mampaso F; Schlöndorff D
    J Am Soc Nephrol; 2004 Jun; 15(6):1504-13. PubMed ID: 15153561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of interstitial macrophages in nephropathy of type 2 diabetic db/db mice.
    Ninichuk V; Khandoga AG; Segerer S; Loetscher P; Schlapbach A; Revesz L; Feifel R; Khandoga A; Krombach F; Nelson PJ; Schlöndorff D; Anders HJ
    Am J Pathol; 2007 Apr; 170(4):1267-76. PubMed ID: 17392166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation.
    Anders HJ; Vielhauer V; Frink M; Linde Y; Cohen CD; Blattner SM; Kretzler M; Strutz F; Mack M; Gröne HJ; Onuffer J; Horuk R; Nelson PJ; Schlöndorff D
    J Clin Invest; 2002 Jan; 109(2):251-9. PubMed ID: 11805137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of C-C chemokine receptors 1 and 5 and CCL3/macrophage inflammatory protein-1alpha in the cutaneous Arthus reaction: possible attenuation of their inhibitory effects by compensatory chemokine production.
    Yanaba K; Mukaida N; Matsushima K; Murphy PM; Takehara K; Sato S
    Eur J Immunol; 2004 Dec; 34(12):3553-61. PubMed ID: 15517609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with BX471, a CC chemokine receptor 1 antagonist, attenuates systemic inflammatory response during sepsis.
    He M; Horuk R; Moochhala SM; Bhatia M
    Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1173-80. PubMed ID: 17234893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine receptor CCR1: a new target for progressive kidney disease.
    Ninichuk V; Anders HJ
    Am J Nephrol; 2005; 25(4):365-72. PubMed ID: 16088077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium.
    Yamagami S; Hamrah P; Miyamoto K; Miyazaki D; Dekaris I; Dawson T; Lu B; Gerard C; Dana MR
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1201-7. PubMed ID: 15790880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephroprotective effect of the HMG-CoA-reductase inhibitor cerivastatin in a mouse model of progressive renal fibrosis in Alport syndrome.
    Koepke ML; Weber M; Schulze-Lohoff E; Beirowski B; Segerer S; Gross O
    Nephrol Dial Transplant; 2007 Apr; 22(4):1062-9. PubMed ID: 17287218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laminin compensation in collagen alpha3(IV) knockout (Alport) glomeruli contributes to permeability defects.
    Abrahamson DR; Isom K; Roach E; Stroganova L; Zelenchuk A; Miner JH; St John PL
    J Am Soc Nephrol; 2007 Sep; 18(9):2465-72. PubMed ID: 17699809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidences of the cooperative role of the chemokines CCL3, CCL4 and CCL5 and its receptors CCR1+ and CCR5+ in RANKL+ cell migration throughout experimental periodontitis in mice.
    Repeke CE; Ferreira SB; Claudino M; Silveira EM; de Assis GF; Avila-Campos MJ; Silva JS; Garlet GP
    Bone; 2010 Apr; 46(4):1122-30. PubMed ID: 20053385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR2 expression by brain microvascular endothelial cells is critical for macrophage transendothelial migration in response to CCL2.
    Dzenko KA; Song L; Ge S; Kuziel WA; Pachter JS
    Microvasc Res; 2005 Jul; 70(1-2):53-64. PubMed ID: 15927208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential roles of the CC chemokine ligand 3-CC chemokine receptor 5 axis in bleomycin-induced pulmonary fibrosis through regulation of macrophage and fibrocyte infiltration.
    Ishida Y; Kimura A; Kondo T; Hayashi T; Ueno M; Takakura N; Matsushima K; Mukaida N
    Am J Pathol; 2007 Mar; 170(3):843-54. PubMed ID: 17322370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the chemokine receptor CCR1 in human renal allografts.
    Mayer V; Hudkins KL; Heller F; Schmid H; Kretzler M; Brandt U; Anders HJ; Regele H; Nelson PJ; Alpers CE; Schlöndorff D; Segerer S
    Nephrol Dial Transplant; 2007 Jun; 22(6):1720-9. PubMed ID: 17298994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thioredoxin-1 ameliorates myosin-induced autoimmune myocarditis by suppressing chemokine expressions and leukocyte chemotaxis in mice.
    Liu W; Nakamura H; Shioji K; Tanito M; Oka S; Ahsan MK; Son A; Ishii Y; Kishimoto C; Yodoi J
    Circulation; 2004 Sep; 110(10):1276-83. PubMed ID: 15337697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1-dependent sequential chemokine expression and inflammatory cell infiltration in ischemia-reperfusion injury.
    Furuichi K; Wada T; Iwata Y; Kokubo S; Hara A; Yamahana J; Sugaya T; Iwakura Y; Matsushima K; Asano M; Yokoyama H; Kaneko S
    Crit Care Med; 2006 Sep; 34(9):2447-55. PubMed ID: 16849996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR2 blockade impairs angiotensin II-induced CC chemokine synthesis and mononuclear leukocyte infiltration.
    Abu Nabah YN; Losada M; Estellés R; Mateo T; Company C; Piqueras L; Lopez-Gines C; Sarau H; Cortijo J; Morcillo EJ; Jose PJ; Sanz MJ
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2370-6. PubMed ID: 17717298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.